With a grateful nod to the past and a bright eye on the future, the Duke Clinical and Translational Science Institute (CTSI) officially opened its expanded space Wednesday on the North Carolina Research Campus.
Duke doubled its presence on the campus to 10,100 square feet, all of it home to the Translational Population Health Research Center, or “TransPop.”
“As we enter the second decade of our foundational MURDOCK Study, we have doubled our TransPop office space to accommodate even larger and more complex studies,” said Dr. Kristin Newby, director of TransPop and principal investigator for the MURDOCK Study. “We are looking forward to new collaborations that leverage the MURDOCK Study asset, as well as other projects based here in Kannapolis that are seeking to improve health.”
From Duke’s expansive office suite on the third floor of the NCRC Medical Plaza, the crowd at the grand opening enjoyed a wonderful view of the new Kannapolis Sports and Entertainment Venue — the future home of the Kannapolis Cannon Ballers baseball team.
“Duke and the MURDOCK Study have helped put us on the map as a city where groundbreaking, community-based research is taking place,” Kannapolis Mayor Darrell Hinnant said. “Kannapolis is proud to be the home of the MURDOCK Study, and we look forward to upcoming studies made possible by Duke’s expansion on the North Carolina Research Campus.”
From humble beginnings in 2007 in a former downtown retail shop with one employee, Duke CTSI now has 27 employees in Kannapolis and 12,526 volunteers in the MURDOCK Study, plus hundreds more in other studies. Duke studies aim to better understand the transition between health and disease at the clinical, community, and molecular level, and ultimately contribute to improved diagnosis and treatment.
“I’m so pleased to see Duke expanding. In doubling their space, Duke joins the seven UNC System universities that have expanded their campus footprint within the past year,” said Mark Spitzer, president of Castle & Cooke NC, developer of the NC Research Campus. “Duke’s MURDOCK Study and other longitudinal health studies are particularly important to the overall mission of the North Carolina Research Campus, and Duke’s community-based research is vital as the campus grows through the increasing participation of each entity toward improving human health.”
Many Duke researchers and leaders arrived from Durham for the event, including Dr. Ebony Boulware, director of the Duke Clinical and Translational Science Institute (CTSI), who congratulated the TransPop team on what they have built in Kannapolis.
“Not only is vital clinical research taking place here, but TransPop always places study participants at the center of everything they do,” Boulware said. “This community-based approach is the gold standard, and investigator after investigator tells me of their remarkable experience working with this team on grants, projects, and initiatives. Thank you for the important work you do for Duke CTSI and for Duke University as a whole. TransPop ensures that clinical research continues to flourish at Duke and in our North Carolina communities, and that the knowledge gained through research at Duke will improve the health of our communities.”
TRANSPOP BY THE NUMBERS
The TransPop space in Kannapolis now features:
10,100 total square feet
12 exam rooms
Expanded lab space
Expanded reception area
Visiting faculty workspace
Large multipurpose room
TransPop milestones in Kannapolis include:
12,526 study participants and 429,215 biological samples in the MURDOCK Study Community Registry and Biorepository
More than 50 collaborations, including 148 PI collaborations across 22 institutions
54 peer-reviewed publications
Duke faculty have used MURDOCK Study samples or data to explore a broad range of research questions about many different diseases
Four nested sub-cohorts of the MURDOCK Study and 50 other projects, including the new Duke TransPop Volunteer Registry, an online registry with more than 1,000 registrants
ABOUT THE MURDOCK STUDY
The MURDOCK Study Community Registry and Biorepository is Duke’s landmark longitudinal translational research study working to reclassify health and disease through advanced scientific technologies, expertise from Duke researchers, and close collaboration with a strong network of community partners. One of the largest and most unique studies of its kind in the world, the MURDOCK Study ultimately aims to identify linkages across major diseases and disorders to help defeat some of today’s leading causes of illness and death.
MURDOCK is an acronym that stands for Measurement to Understand the Reclassification of Disease Of Cabarrus and Kannapolis. Duke University School of Medicine received a generous from David H. Murdock through the David H. Murdock Institute for Business and Culture to establish the MURDOCK Study in September 2007. The first participant was enrolled in 2009.
For more information, visit duketranspop.org.
ABOUT DUKE CTSI
The Duke Clinical and Translational Institute (CTSI) catalyzes and accelerates the innovation and translation of scientific discoveries into health benefits for patients and communities through collaborative research. Our NIH Clinical and Translational Science Award funding enables us to offer programs, project management and navigator services, and data sharing and informatics resources that provide essential support to move ideas from the laboratory through early-phase clinical trials, and facilitate education for current and future translational medicine researchers.
For more information, visit ctsi.duke.edu.